Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3450 of 3546 entries
View as:

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD

Phase: N/A Priority: Normal
NCT ID: NCT01516437 Org: User:
Start: 02/01/12 End: 12/20/12 Due: 12/20/13

Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

Phase: N/A Priority: Normal
NCT ID: NCT06577597 Org: User:
Start: 09/02/24 End: 11/01/24 Due: 11/01/25

Aura Adolescent PK Study GSK2829332

Phase: N/A Priority: Normal
NCT ID: NCT01653483 Org: User:
Start: 09/30/12 End: 03/31/13 Due: 03/31/14

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03447314 Org: User:
Start: 03/26/18 End: 03/11/22 Due: 03/11/23

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT03866187 Org: User:
Start: 03/28/19 End: 10/07/24 Due: 10/07/25

WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide

Phase: N/A Priority: Normal
NCT ID: NCT01607333 Org: User:
Start: 12/31/11 End: 07/31/14 Due: 07/31/15

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

Phase: N/A Priority: Normal
NCT ID: NCT00697866 Org: User:
Start: 08/31/00 End: - Due: -

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01431937 Org: User:
Start: 10/10/10 End: 03/29/11 Due: 03/29/12

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00624819 Org: User:
Start: 03/03/08 End: 06/02/08 Due: 06/02/09

Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

Phase: N/A Priority: Normal
NCT ID: NCT01360398 Org: User:
Start: 06/30/11 End: 06/27/14 Due: 06/27/15

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

Phase: N/A Priority: Normal
NCT ID: NCT02545517 Org: User:
Start: 10/05/15 End: 12/23/22 Due: 12/23/23

RELOVAIR® Lung Deflation Study

Phase: N/A Priority: Normal
NCT ID: NCT01691885 Org: User:
Start: 11/30/12 End: 08/31/14 Due: 08/31/15

A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days

Phase: N/A Priority: Normal
NCT ID: NCT00964340 Org: User:
Start: 10/01/09 End: 04/27/10 Due: 04/27/11

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02298179 Org: User:
Start: 12/19/14 End: 03/27/17 Due: 03/27/18

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Phase: N/A Priority: Normal
NCT ID: NCT06959095 Org: User:
Start: 06/06/25 End: 08/06/29 Due: 08/06/30

Study of GSK3511294 in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05140200 Org: User:
Start: 12/10/21 End: 12/23/22 Due: 12/23/23

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00321763 Org: User:
Start: 04/27/06 End: 07/07/06 Due: 07/07/07

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostrate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06990880 Org: User:
Start: 06/18/25 End: 08/23/28 Due: 08/23/29

Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00675064 Org: User:
Start: 05/02/08 End: 10/12/08 Due: 10/12/09

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00067951 Org: User:
Start: 10/17/03 End: 11/30/04 Due: 11/30/05

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

Phase: N/A Priority: Normal
NCT ID: NCT02377427 Org: User:
Start: 08/25/15 End: 01/31/18 Due: 01/31/19

Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

Phase: N/A Priority: Normal
NCT ID: NCT02889809 Org: User:
Start: 07/10/17 End: 06/04/21 Due: 06/04/22

Study Of RV-39 In Patients Who Also Have Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00503009 Org: User:
Start: 10/31/07 End: 07/31/08 Due: 07/31/09

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02548052 Org: User:
Start: 10/22/15 End: 02/19/16 Due: 02/19/17

A Safety Study to Investigate the Skin Sensitization Potential of MFC51123

Phase: N/A Priority: Normal
NCT ID: NCT02192203 Org: User:
Start: 04/01/14 End: 07/15/14 Due: 07/15/15